A detailed history of Black Rock Inc. transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Black Rock Inc. holds 1,994,588 shares of TAK stock, worth $25.9 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,994,588
Previous 1,771,942 12.57%
Holding current value
$25.9 Million
Previous $25.3 Million 9.57%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

BUY
$13.89 - $15.04 $3.09 Million - $3.35 Million
222,646 Added 12.57%
1,994,588 $27.7 Million
Q4 2023

Feb 13, 2024

SELL
$13.36 - $15.43 $6.98 Million - $8.06 Million
-522,527 Reduced 22.77%
1,771,942 $25.3 Million
Q3 2023

Nov 13, 2023

SELL
$15.03 - $16.32 $1.69 Million - $1.83 Million
-112,430 Reduced 4.67%
2,294,469 $35.5 Million
Q2 2023

Aug 11, 2023

SELL
$15.57 - $17.11 $2.17 Million - $2.38 Million
-139,117 Reduced 5.46%
2,406,899 $37.8 Million
Q1 2023

May 12, 2023

BUY
$15.28 - $16.48 $7.03 Million - $7.58 Million
460,180 Added 22.06%
2,546,016 $42 Million
Q4 2022

Feb 13, 2023

SELL
$12.42 - $15.62 $1.8 Million - $2.27 Million
-145,161 Reduced 6.51%
2,085,836 $32.6 Million
Q3 2022

Nov 14, 2022

BUY
$12.8 - $28.65 $681,395 - $1.53 Million
53,234 Added 2.44%
2,230,997 $28.9 Million
Q2 2022

Aug 12, 2022

SELL
$13.12 - $15.03 $11.1 Million - $12.7 Million
-843,511 Reduced 27.92%
2,177,763 $30.6 Million
Q1 2022

May 12, 2022

BUY
$13.54 - $15.35 $11.4 Million - $12.9 Million
842,139 Added 38.65%
3,021,274 $43.3 Million
Q4 2021

Feb 10, 2022

BUY
$13.17 - $16.4 $4.81 Million - $5.99 Million
365,186 Added 20.13%
2,179,135 $29.7 Million
Q3 2021

Nov 09, 2021

BUY
$16.3 - $17.26 $2.26 Million - $2.39 Million
138,422 Added 8.26%
1,813,949 $29.7 Million
Q2 2021

Aug 11, 2021

BUY
$16.55 - $18.64 $27.7 Million - $31.2 Million
1,675,527 New
1,675,527 $28.2 Million

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $40.4B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.